| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Sealbond Ltd | 83% | +419% | $164,022,057 | +$162,616,360 | 24,664,971 | +11568% | CK Life Sciences Int'l., (Holdings) Inc. | 21 Nov 2025 |
| Orca Capital AG | 3.7% | -40% | $390,299 | -$256,967 | 69,821 | -40% | Orca Capital AG | 14 Mar 2025 |
As of 30 Sep 2025, 12 institutional investors reported holding 38,897 shares of Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX). This represents 0.13% of the company’s total 29,716,833 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 48,604 | $202,197 | +$46,664 | $4.16 | 5 |
| 2025 Q3 | 38,897 | $299,516 | -$33,184 | $7.70 | 12 |
| 2025 Q2 | 43,200 | $207,544 | -$197,053 | $4.77 | 10 |
| 2025 Q1 | 81,969 | $409,793 | +$256,592 | $5.01 | 13 |
| 2024 Q4 | 30,770 | $76,511 | +$76,491 | $2.49 | 10 |